Andreas Brunner serves as the Head of the Pharma Business Unit at PHT International Inc., a distinguished Contract Research, Development, and Manufacturing Organization (CRDMO) based in North Carolina. With a robust portfolio that includes PHT Pharma and PHT PharmaTech, Andreas is at the forefront of...
Andreas Brunner serves as the Head of the Pharma Business Unit at PHT International Inc., a distinguished Contract Research, Development, and Manufacturing Organization (CRDMO) based in North Carolina. With a robust portfolio that includes PHT Pharma and PHT PharmaTech, Andreas is at the forefront of delivering innovative development and production solutions tailored for leading life science companies. His role encompasses comprehensive P&L responsibility for the Pharma business unit, overseeing operations in both Shangyu and Nantong, China. This dual-site management not only highlights his leadership capabilities but also underscores his expertise in navigating complex regulatory environments and ensuring compliance with stringent quality assurance standards.
Under Andreas's guidance, the Pharma business unit has embarked on several key projects aimed at advancing the development of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). His deep understanding of chemical process research and development enables him to spearhead initiatives that enhance operational efficiency and drive technological transfer across global teams. Andreas's proficiency in project portfolio management ensures that resources are optimally allocated to high-impact projects, fostering innovation while maintaining a keen eye on investment management.
A recognized leader in the industry, Andreas is adept at coordinating multidisciplinary teams to achieve strategic objectives, particularly in the realm of monoclonal antibodies and other biopharmaceuticals. His analytical chemistry skills complement his operational acumen, allowing him to make data-driven decisions that propel PHT International Inc. to new heights in the competitive pharma landscape. Through his strategic vision and commitment to excellence, Andreas Brunner continues to shape the future of pharmaceutical development at PHT International Inc.
